Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research) - Image 1

£101.05

Springer Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research)

Name: Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research)
Brand: Springer
Price: 101.05 GBP
Availability: InStock

Economics

This is the most expensive it has ever been. Walk away.

£101 today · previous high £101 · all-time low £86

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 633 days • 633 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 633 days • 7 price levels

Days at Price

Current Price

Price Analysis

Most common price: £86 (317 days, 50.1%)

Price range: £86 - £101

Price levels: 7 different prices over 633 days

Description

This is the first book published that focuses on competition law and policy in the Japanese pharmaceutical sector. It consists of chapters written and edited by academics who research the industry from various perspectives, including economics, competition law, pharmaceutical regulations, and intellectual property law. Competition policies involving pharmaceutical products attract attention from academics and policymakers worldwide. The pharmaceutical industry is regulated by drug laws that vary from country to country and are affected by differing practices and industrial structures. The book begins by examining drug regulations and trade practices in the industry that are peculiar to Japan and its healthcare system. It then presents the Japanese Antimonopoly Act and cases involving it, and discussions of current competition law issues in the Japanese pharmaceutical industry. The book also discusses innovation and intellectual property and economic analyses of pharmaceutical regulations and drug discovery. The chapters include comparative studies on Japanese regulations vs. those in the European Union and the United States. Japan is one of the biggest pharmaceutical markets in the world. With this in mind, the book provides “one-stop shopping” for anyone interested in pharmaceutical regulations in the country. Covering the basics but extending to in-depth explorations of complex problems, this book appeals not only to students and academics, pharmaceutical companies and regulators, but also to those dealing with real-world policy issues that encompass competition policy, intellectual property, and pharmaceutical regulation. Chapter 11 is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com

Product Specifications

Brand: Springer
Format: Hardcover
ASIN: 9811678138
Category: Books > Subjects > Business, Finance & Law > Economics
Domain: Amazon UK
Release Date: 09 February 2022
Listed Since: 08 October 2021

Barcode

No barcode data available

Springer Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

EU Law of Competition and Trade in the Pharmaceutical Sector (Elgar Competition Law and Practice series)

Pharmaceutical Innovation, Competition and Patent Law: A Trilateral Perspective

Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow’s World

Edward Elgar - Intellectual Property, Pharmaceuticals and Public Health

Pharmaceutical Antitrust: An Analysis of US and EU Law

EU Competition Law and Pharmaceuticals (New Horizons in Competition Law and Economics series)

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

The Pharmaceutical Industry: A Guide to Historical Records (Studies in British Business Archives)

Research Handbook on International Competition Law

The Politics of Pharmaceutical Policy Reform: A Study of Generic Drug Regulation in Brazil: 26 (SpringerBriefs in Political Science, 26)

PHARMACEUTICAL ECONOMICS AND POLICY 3RD EDITION: Perspectives, Promises, and Problems

Das europäische Arzneimittelrecht: Zentrale Rechtsfragen des Arzneimittelzulassungsverfahrens

Global Issues in Pharmaceutical Marketing

Routledge Pharmaceutical Industry and Public Policy in India

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

Pharmaceuticals, Corporate Crime and Public Health

Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries

Routledge: The Japanese Pharmaceutical Industry Evolution Book

Springer - Innovation and Marketing in Pharmaceutical Industry

Economics of the Pharmaceutical and Medical Device Industry: Supply Chain, Trade and Innovation (Routledge Studies in the Economics of Innovation)

Economics of Drug R&D:Financing, Strategic and Policy Considerations; Price Regulation,Capital Market Imperfections and Strategic R&D Investment Behavior in the Pharmaceutical Industry

Guide to EU and UK Pharmaceutical Regulatory Law

Poor Quality Pharmaceuticals in Global Public Health: 5 (Trust, 5)

The Public Financing of Pharmaceuticals: An Economic Approach